DrugPatentWatch Database Preview
Portola Pharms Inc Company Profile
What is the competitive landscape for PORTOLA PHARMS INC, and when can generic versions of PORTOLA PHARMS INC drugs launch?
PORTOLA PHARMS INC has one approved drug.
There are ten US patents protecting PORTOLA PHARMS INC drugs.
Summary for Portola Pharms Inc
| US Patents: | 10 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Portola Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | RX | Yes | Yes | 6,376,515 | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | ||
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | RX | Yes | No | 7,598,276 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Portola Pharms Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2013514380 | ➤ Try a Free Trial |
| Norway | 20021230 | ➤ Try a Free Trial |
| Germany | 60040676 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
